Skip to main content
. 2020 Mar 27;3(1):32–39. doi: 10.1002/agm2.12098

Table 1.

Clinical and laboratory data of patients with CKD stratified by eGFR

Variable All patients eGFR P
>90 90‐60 60‐30 30‐15 <15
n 160 10 51 38 32 26  
Age (years) 75.29 ± 12.08 55 ± 4.690* 74.13 ± 11.86 76.87 ± 11.08 80.52 ± 7.779 73.23 ± 13.00 <.0001
Sex, M/F 99/61 7/3 32/19 20/18 16/16 20/6  
BMI, kg/m2 21.8 ± 4.0 22.4 ± 5.3 21.7 ± 4.5 21.4 ± 3.7 20.8 ± 4.8 20.4 ± 3.2 .32
NGAL (ng/mL) 402.9 ± 285.2 157.6 ± 64.04 228.3 ± 127.3 346.9 ± 159.4 552.9 ± 323.5 729.5 ± 282.7 <.0001
CysC (mg/L) 3.038 ± 2.489 0.9230 ± 0.2486 1.367 ± 0.4260 2.776 ± 1.610 4.445 ± 1.971 5.771 ± 3.455 <.0001
eGFR (mL/mim/1.73 m2) 47.5 ± 28.06 94.54 ± 3.036 75.31 ± 8.281 44.06 ± 8.620 23.51 ± 3.905 10.60 ± 2.463 <.0001
Urea (mmol/L) 14.24 ± 9.377 5.724 ± 1.554 6.755 ± 2.557 12.67 ± 5.724 19.67 ± 6.197 26.82 ± 8.776 <.0001
Cr (μmol/L) 207 ± 195.7 65.00 ± 14.77 75.72 ± 19.62 132.8 ± 26.48 237.6 ± 51.46 585.7 ± 186.3 <.0001
UA (μmol/L) 350.6 ± 119.4 333.3 ± 53.62 318.8 ± 86.28 355.4 ± 147.7 345.4 ± 98.26 409.8 ± 150.7 .0906
Ca (mmol/L) 2.16 ± 0.1747 2.319 ± 0.1331 2.191 ± 0.1538 2.200 ± 0.1520 2.155 ± 0.1372 2.004 ± 0.2084 <.0001
Phos (mmol/L) 1.207 ± 0.3368 1.156 ± 0.1884 1.057 ± 0.1875 1.124 ± 0.2029 1.271 ± 0.3394 1.543 ± 0.4805 <.0001
ALT (U/L) 18.6 ± 14.94 24.29 ± 8.365 20.59 ± 15.57 15.92 ± 5.569 15.72 ± 12.72 17.70 ± 23.72 .3917
AST (U/L) 22.54 ± 17.70 22.57 ± 3.666 23.40 ± 14.45 21.49 ± 5.773 25.98 ± 34.03 18.27 ± 5.920 .6396
ALP (U/L) 98.22 ± 53.85 79.48 ± 23.98 88.53 ± 45.82 94.70 ± 26.31 103.5 ± 76.31 123.6 ± 66.66 .0886
GGT (U/L) 41.06 ± 65.09 24.43 ± 17.80 31.57 ± 27.24 37.01 ± 19.68 32.86 ± 26.20 53.38 ± 48.41 .4123
TC (mmol/L) 4.289 ± 1.153 4.809 ± 0.7166 4.322 ± 1.261 4.250 ± 1.248 4.410 ± 0.9596 4.085 ± 1.246 .6019
TG (mmol/L) 1.592 ± 1.567 1.387 ± 0.7574 1.833 ± 2.320 1.433 ± 0.7608 1.616 ± 1.249 1.480 ± 1.034 .8049
HDL‐C (mmol/L) 0.9985 ± 0.3106 1.263 ± 0.4109 1.043 ± 0.3243 1.030 ± 0.2978 0.9489 ± 0.2208 0.8235 ± 0.2602 .0025
LDL‐C (mmol/L) 2.797 ± 0.8249 3.178 ± 0.5335 2.716 ± 0.9717 2.775 ± 0.8628 2.969 ± 0.6507 2.750 ± 0.7946 .4895
LPa (mg/L) 376 ± 347.6 419.1 ± 392.8 321.0 ± 364.5 409.1 ± 391.6 427.4 ± 290.7 393.3 ± 328.6 .7153
TP (g/L) 62.19 ± 7.541 64.96 ± 5.790 61.20 ± 9.428 64.00 ± 8.401 62.24 ± 5.811 61.27 ± 4.090 .4167
ALB (g/L) 34.3 ± 5.119 39.72 ± 4.067 35.11 ± 6.225 34.36 ± 4.574 32.69 ± 3.164 32.47 ± 3.872 .0015
CRP (mg/L) 4.4 ± 1.5 3.4 ± 2.7 5.7 ± 1.9 4.0 ± 1.3 5.4 ± 1.7 4.6 ± 1.2 .56
RBC (1012/L) 3.567 ± 0.7640 4.470 ± 0.4642 3.955 ± 0.6736 3.774 ± 0.6556 3.048 ± 0.5585 3.071 ± 0.5866 <.0001
HGB (g/L) 108.1 ± 22.43 134.0 ± 14.05 119.6 ± 21.96 113.3 ± 17.00 92.59 ± 16.38 95.22 ± 15.97 <.0001
HCT % 32.65 ± 6.687 40.15 ± 4.082 36.18 ± 6.122 34.24 ± 4.889 27.74 ± 5.207 28.73 ± 5.061 <.0001
MCV (fL) 91.72 ± 5.992 90.77 ± 4.073 91.47 ± 6.468 91.12 ± 6.706 91.13 ± 4.601 94.01 ± 5.882 .3929
MCH (pg) 30.44 ± 2.189 30.45 ± 1.787 30.20 ± 2.546 30.12 ± 2.160 30.47 ± 1.469 31.21 ± 2.295 .419
MCHC (g/L) 331.9 ± 11.41 335.7 ± 7.146 330.0 ± 12.19 330.8 ± 10.77 334.6 ± 11.11 332.0 ± 12.40 .4829

P‐values are for comparison across all six groups from one‐way analysis of variance.

Abbreviations: ALB, albumin; ALT, alanine aminotransferase; ALP, alkaline phosphatase; AST, aspertate transferase; BMI, body mass index; Ca, calcium; Cr, creatinine; CRP, C‐reactive protein; CysC, cystatin C; eGFR, evaluated glomerular filtration rate; GGT, gamma‐glutamyl transferase; HCT, hematocrit; HDL‐C, high‐density lipoprotein cholesterol; HGB, hemoglobin; LDL‐C, low density lipoproteincholesterol; LPa, lipoprotein a; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin contentration; MCV, mean corpuscular volume; NGAL, neutrophil gelatinase‐associated lipocalin; Phos, phosphorus; RBC, red blood cell; TC, total cholesterol; TG, Total triglyceride; TP, total protein; UA, uric acid .